Abstract
210 - Assessment of Healthcare Resource Utilization (HCRU) and Hospitalization Costs in Patients (pts) with Relapsed or Refractory (r/r) Follicular Lymphoma (FL) Undergoing CAR-T Cell Therapy with Tisagenlecleucel: Results from the Elara Study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
